Across the United States, patients who have received Tepezza infusions to treat thyroid eye disease (TED) are stepping forward to file lawsuits after experiencing hearing-related problems, including persistent subjective hearing loss, severe hearing impairment, and permanent hearing loss. By November 2024, the Tepezza multidistrict litigation (MDL) reached a significant milestone, consolidating 191 Tepezza hearing loss cases in the Northern District of Illinois. Plaintiffs allege that Horizon Therapeutics failed in adequately warning patients and doctors of the risks of hearing damage, including worsening sensorineural hearing loss. As the litigation advances, many Tepezza users are now seeking justice and compensation for their injuries.
If you are among the patients who have suffered hearing loss or tinnitus after taking Tepezza, you may be eligible to file a Tepezza lawsuit. Mass Tort America’s legal team helps patients nationwide navigate this complex process, offering a free case evaluation and guidance tailored to their needs. From filing a Tepezza hearing loss lawsuit to coordinating medical evaluations, our Concierge Team is here to assist you every step of the way.
Tepezza Lawsuit Overview
Tepezza is a prescription medication specifically designed to treat thyroid eye disease (TED), a condition marked by inflammation and damage to the tissues surrounding the eyes. This drug operates by inhibiting the activity of the insulin-like growth factor 1 receptor (IGF-1R), which plays a crucial role in the progression of TED. Administered intravenously over a period of three to six months, Tepezza has demonstrated significant efficacy in alleviating symptoms such as eye bulging, double vision, and eye pain in patients with active TED. By targeting the underlying mechanisms of thyroid eye disease, Tepezza offers a promising treatment option for those suffering from this debilitating condition.
What Is Tepezza Used For?
Tepezza is primarily used to treat thyroid eye disease (TED), an autoimmune condition often associated with hyperthyroidism. TED leads to inflammation and damage in the tissues around the eyes, resulting in a range of symptoms from mild to severe. The most prominent symptom is exophthalmos or proptosis, where the eyes bulge outward. Other symptoms include blurred vision, double vision, eye misalignment, chronic redness, swelling near the eyelids, light sensitivity, and difficulty moving the eyes. By addressing these symptoms, Tepezza helps improve the quality of life for patients dealing with the challenges of thyroid eye disease.
Why patients Are Filing Tepezza Hearing Loss Lawsuits
Tepezza, the first FDA-approved treatment for thyroid eye disease, was initially celebrated for its ability to address symptoms like double vision and blurred vision. However, many patients who received Tepezza infusions subsequently suffered permanent hearing loss, ranging from temporary hearing problems to potentially permanent hearing loss. Plaintiffs in the Tepezza litigation argue that Horizon Therapeutics failed to provide adequate warnings regarding the risks of permanent hearing impairment, leaving patients unaware of these severe side effects.
The hearing loss lawsuits claim that the drug’s clinical trials underestimated the risks, describing hearing-related problems as rare and temporary. Many plaintiffs now argue that they developed permanent hearing loss, sensorineural hearing loss, or persistent subjective hearing loss after treatment. Some individuals experienced serious hearing loss severe enough to impact their daily lives, leading to additional medical expenses for treatment and rehabilitation.
Tepezza hearing loss claims allege that Horizon Therapeutics had sufficient evidence to provide better guidance to doctors and patients but chose not to do so. The lawsuits claim that by failing to adequately warn patients, the company put countless individuals at risk of suffering permanent hearing loss and hearing damage. These cases have now been consolidated into the Tepezza hearing loss MDL to ensure a fair and efficient legal process for plaintiffs nationwide.
The Progress Of The Tepezza Hearing Loss MDL
The Tepezza multidistrict litigation (MDL) was established to consolidate Tepezza lawsuits into a single jurisdiction for pretrial proceedings. Overseen by Judge Thomas Durkin in the Northern District of Illinois, this consolidation allows plaintiffs to hear oral arguments and share evidence efficiently. The MDL currently includes 191 Tepezza cases, with new claims being added as more patients come forward. By consolidating Tepezza lawsuits, the judicial panel aims to streamline the litigation process while ensuring consistent rulings across similar claims.
At the heart of the litigation is the discovery phase, where plaintiffs’ legal teams gather evidence to support their claims. This process includes obtaining internal documents, expert testimony, and medical evaluations to demonstrate that Horizon Therapeutics failed to provide adequate warnings about Tepezza-related hearing loss. Tepezza lawsuits claim that Horizon Therapeutics failed to inform patients and healthcare providers about the risk of hearing loss associated with the drug. Recent disputes over depositions have caused minor delays, but the court remains committed to moving the process forward.
The next significant step in the Tepezza hearing loss MDL is the bellwether trials, scheduled to begin in March 2026. These trials will test the strength of the plaintiffs’ claims before a jury and provide insight into potential outcomes for other Tepezza users. For those who suffered hearing loss, these trials are a critical step toward holding Horizon Therapeutics accountable and seeking fair compensation for their injuries.
August 29, 2024 – Slow Progress In Tepezza MDL
As of August 29, 2024, the Tepezza multidistrict litigation (MDL) has experienced slow progress, with the next status conference scheduled for September 5, 2024. The defense has filed a motion to dismiss a bellwether discovery case, with oral arguments set for October 16, 2024. While the decision will only impact that specific case, it may have broader implications for the overall litigation. These developments highlight the ongoing complexities and challenges within the Tepezza MDL, as both sides continue to prepare for the upcoming bellwether trials.
Understanding Eligibility And Compensation For Tepezza Hearing Loss claims
Patients who experienced hearing-related problems after taking Tepezza may be eligible to file a Tepezza lawsuit. Eligibility often depends on whether individuals suffered permanent hearing damage, significant hearing impairments, or hearing loss after receiving Tepezza infusions. These cases focus on establishing a connection between Tepezza and the patient’s hearing loss or tinnitus while highlighting the manufacturer’s failure to provide adequate warnings.
Each Tepezza hearing loss case is unique, and the compensation can vary based on the severity of the hearing loss and other individual factors. Compensation in Tepezza hearing loss lawsuits could cover a range of damages, including medical expenses, ongoing treatment costs, and the emotional toll of permanent hearing impairment. For patients with thyroid eye disease, hearing problems can significantly impact their quality of life, creating additional burdens beyond the original condition. The Tepezza litigation aims to address these hardships by holding the manufacturer accountable for its actions.
If you believe you have suffered hearing loss, tinnitus, or other hearing-related issues due to Tepezza, seeking legal guidance is essential. By consulting with Tepezza lawyers, affected individuals can better understand their rights and options for pursuing compensation. A free consultation can help determine if you may be eligible to file a Tepezza hearing damage lawsuit.
Tepezza Discovery And Depositions
Discovery is a critical phase in the litigation process, allowing both parties to gather essential evidence and build their cases. In the Tepezza MDL, discovery has been an ongoing effort, with both parties agreeing to document production by Horizon Therapeutics.
Discovery Progress And Agreement
The Tepezza hearing loss MDL has seen gradual progress, with both parties reaching an agreement on the production of documents by Horizon Therapeutics. This marks a significant step forward in the discovery phase, although the process remains complex and time-consuming. It may take several months or even years to complete.
In addition to document production, the parties have agreed on a protocol for the handling of electronically stored information (ESI). This protocol outlines the procedures for collecting, processing, and producing ESI, which is vital for building a robust case.
The discovery process is crucial in Tepezza lawsuits, as it enables plaintiffs to gather the necessary evidence to support their claims of permanent hearing loss and other hearing-related issues. If you have suffered hearing damage or hearing loss after taking Tepezza, it is essential to consult with a Tepezza lawyer to explore your options and determine the best course of action for your case.
Our Tepezza lawyers are well-versed in handling complex litigation and can guide you through the discovery process. We offer free consultations and case reviews to assess your potential case and determine the best strategy for seeking compensation for your injuries. Contact us today to learn more about your options and how we can assist you in pursuing justice for your hearing loss.
How Can Mass Tort America Help With Your Tepezza case?
Mass Tort America specializes in helping patients across the country who have developed permanent hearing loss or severe hearing impairment due to Tepezza. Tepezza is the first and only medication approved specifically for treating thyroid eye disease, highlighting its significance in the market. Our legal team works closely with affected individuals to build strong cases, ensuring that every aspect of their hearing damage and related losses is accounted for. Whether you are dealing with persistent sensorineural hearing loss or other forms of hearing impairment, we can help you seek the compensation you may deserve.
With a nationwide reach and a dedicated Concierge Team, Mass Tort America makes it easier to take action, no matter where you live. From evaluating your eligibility to file a Tepezza lawsuit to helping you navigate the complexities of multidistrict litigation, we are committed to guiding you every step of the way. Call us at 800-356-4338 or fill out our contact form at https://masstortamerica.com/contact/ to schedule your free consultation today.
